Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors

Journal of General Virology

Volumn 87, Issue 2, 2006, Pages 255-265

  Verhaagh, Sandra ^a   de Jong, Esmeralda ^a   Goudsmit, Jaap ^a   Lecollinet, Sylvie ^b   Gillissen, Gert ^a   de Vries, Margreet ^c   van Leuven, Kees ^c   Que, Ivo ^d   Ouwehand, Krista ^a   Mintardjo, Ratna ^a   Weverling, Gerrit Jan ^a   Radošević, Katarina ^a   Richardson, Jennifer ^b   Eloit, Marc ^b   Lowik, Clemens ^d   Quax, Paul ^c   Havenga, Menzo ^a  

^a CRUCELL HOLLAND BV   (Netherlands)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c TNO   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CD8 ANTIGEN; GAG PROTEIN; LUCIFERASE; MEMBRANE COFACTOR PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CAMERA; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG POTENCY; DRUG SAFETY; FEMALE; GENE EXPRESSION; HUMAN ADENOVIRUS; IMAGING SYSTEM; KIDNEY CELL; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; MOUSE STRAIN; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION; WILD TYPE;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIGENS, CD46; GENETIC VECTORS; HUMANS; MICE; MICE, TRANSGENIC; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS; MUS MUSCULUS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 31644432773     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81293-0     Document Type: Article

References (59)

1. Barouch, D. H., Pau, M. G., Custers, J. H. & 15 other authors (2004). Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J Immunol 172, 6290-6297.
2. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L. & Finberg, R. W. (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
3. Cao, B., Pruchnic, R., Ikezawa, M., Xiao, X., Li, J., Wickham, T. J., Kovesdi, I., Rudert, W. A. & Huard, J. (2001). The role of receptors in the maturation-dependent adenoviral transduction of myofibers. Gene Ther 8, 627-637.
4. de Bruijn, J. D., van den Brink, I., Mendes, S., Dekker, R., Bovell, Y. P. & van Blitterswijk, C. A. (1999). Bone induction by implants coated with cultured osteogenic bone marrow cells. Adv Dent Res 13, 74-81.
5. Dorig, R. E., Marcil, A., Chopra, A. & Richardson, C. D. (1993). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305.
6. v-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther 6, 1520-1535.
7. Gaggar, A., Shayakhmetov, D. M. & Lieber, A. (2003). CD46 is a cellular receptor for group B adenoviruses. Nat Med 9, 1408-1412.
8. Goossens, P. H., Havenga, M. J., Pieterman, E., Lemckert, A. A., Breedveld, F. C., Bout, A. & Huizinga, T. W. (2001). Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber. Arthritis Rheum 44, 570-577.
9. Havenga, M. J., Lemckert, A. A., Grimbergen, J. M., Vogels, R., Huisman, L. G., Valerio, D., Bout, A. & Quax, P. H. (2001). Improved adenovirus vectors for infection of cardiovascular tissues. J Virol 75, 3335-3342.
10. Havenga, M. J., Lemckert, A. A., Ophorst, O. J. & 13 other authors (2002). Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J Virol 76, 4612-4620.
11. + adenovirus-specific T cells: implications for immunotherapy and gene therapy. J Virol 77, 6562-6566.
12. Holterman, L., Vogels, R., van der Vlugt, R. & 15 other authors (2004). Novel replication-incompetent vector derived from adeno-virus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. J Virol 78, 13207-13215.
13. Horvat, B., Rivailler, P., Varior-Krishnan, G., Cardoso, A., Gerlier, D. & Rabourdin-Combe, C. (1996). Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J Virol 70, 6673-6681.
14. Hutchin, M. E., Pickles, R. J. & Yarbrough, W. G. (2000). Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression. Hum Gene Ther 11, 2365-2375.
15. Kallstrom, H., Liszewski, M. K., Atkinson, J. P. & Jonsson, A. B. (1997). Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol 25, 639-647.
16. Kemper, C., Leung, M., Stephensen, C. B., Pinkert, C. A., Liszewski, M. K., Cattaneo, R. & Atkinson, J. P. (2001). Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin Exp Immunol 124, 180-189.
17. Klein, D., Janda, P., Steinborn, R., Muller, M., Salmons, B. & Gunzburg, W. H. (1999). Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification. Electrophoresis 20, 291-299.
18. Klein, D., Bugl, B., Gunzburg, W. H. & Salmons, B. (2000). Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR. Gene Ther 7, 458-463.
19. Knaan-Shanzer, S., Van Der Velde, I., Havenga, M. J., Lemckert, A. A., De Vries, A. A. & Valerio, D. (2001). Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B. Hum Gene Ther 12, 1989-2005.
20. Kostense, S., Koudstaal, W., Sprangers, M. & 8 other authors (2004). Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector. AIDS 18, 1213-1216.
21. Kremer, E. J., Boutin, S., Chillon, M. & Danos, O. (2000). Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 74, 505-512.
22. Lamme, E. N., van Leeuwen, R. T., Jonker, A., van Marle, J. & Middelkoop, E. (1998). Living skin substitutes: survival and function of fibroblasts seeded in a dermal substitute in experimental wounds. J Invest Dermatol 111, 989-995.
23. Lamme, E. N., Van Leeuwen, R. T., Brandsma, K., Van Marle, J. & Middelkoop, E. (2000). Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation. J Pathol 190, 595-603.
24. Li, D., Duan, L., Freimuth, P. & O'Malley, B. W., Jr (1999). Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 5, 4175-4181.
25. Manchester, M., Liszewski, M. K., Atkinson, J. P. & Oldstone, M. B. (1994). Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci U S A 91, 2161-2165.
26. Mei, Y. F., Lindman, K. & Wadell, G. (1998). Two closely related adenovirus genome types with kidney or respiratory tract tropism differ in their binding to epithelial cells of various origins. Virology 240, 254-266.
27. Mei, Y. F., Lindman, K. & Wadell, G. (2002). Human adenoviruses of subgenera. B, C, and E with various tropisms differ in both binding to and replication in the epithelial A549 and 293 cells. Virology 295, 30-43.
28. + immune responses in vivo. J Gen Virol 85, 1227-1236.
29. Miyagawa, S., Ikawa, M., Kominami, K., Tanaka, H., Mikata, S., Matsuda, H., Seya, T., Shirakura, R. & Okabe, M. (1997). The regulation of membrane cofactor protein (CD46) expression in transgenic mice: the importance of the first 125 BP of the 3′ untranslated region. Transplant Proc 29, 941-942.
30. Moutsatsos, I. K., Turgeman, G., Zhou, S. & 9 other authors (2001). Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3, 449-461.
31. Nalbantoglu, J., Pari, G., Karpati, G. & Holland, P. C. (1999). Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum Gene Ther 10, 1009-1019.
32. Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C. & Gerlier, D. (1993). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67, 6025-6032.
33. Ni, S., Bernt, K., Gaggar, A., Li, Z.-Y., Kiem, H. P. & Lieber, A. (2005). Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons. Hum Gene Ther 16, 664-677.
34. Nwanegbo, E., Vardas, E., Gao, W., Whittle, H., Sun, H., Rowe, D., Robbins, P. D. & Gambotto, A. (2004). Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States. Clin Diagn Lab Immunol 11, 351-357.
35. Okada, N., Liszewski, M. K., Atkinson, J. P. & Caparon, M. (1995). Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A 92, 2489-2493.
36. Oldstone, M. B., Lewicki, H., Thomas, D. & 7 other authors (1999). Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 98, 629-640.
37. Ophorst, O. J., Kostense, S., Goudsmit, J & 9 other authors (2004). An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. Vaccine 22, 3035-3044.
38. Orlicky, D. J., DeGregori, J. & Schaack, J. (2001). Construction of stable coxsackievirus and adenovirus receptor-expressing 3T3-L1 cells. J Lipid Res 42, 910-915.
39. Rail, G. F., Manchester, M., Daniels, L. R., Callahan, E. M., Belman, A. R. & Oldstone, M. B. (1997). A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci U S A 94, 4659-4663.
40. Rea, D., Havenga, M. J., van Den Assem, M. & 6 other authors (2001a). Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol 166, 5236-5244.
41. Rea, D., Johnson, M. E., Havenga, M. J., Melief, C. J. & Offringa, R. (2001b). Strategies for improved antigen delivery into dendritic cells. Trends Mol Med 7, 91-94.
42. Riesle, J., Hollander, A. P., Langer, R., Freed, L. E. & Vunjak-Novakovic, G. (1998). Collagen in tissue-engineered cartilage: types, structure, and crosslinks. J Cell Biochem 71, 313-327.
43. Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A. & Lusso, P. (1999). CD46 is a cellular receptor for human herpesvirus 6. Cell 99, 817-827.
44. Segerman, A., Atkinson, J. P., Marttila, M., Dennerquist, V., Wadell, G. & Amberg, N. (2003). Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 77, 9183-9191.
45. Seshidhar Reddy, P., Ganesh, S., Limbach, M. P., Brann, T., Pinkstaff, A., Kaloss, M., Kaleko, M. & Connelly, S. (2003). Development of adenovirus serotype 35 as a gene transfer vector. Virology 311, 384-393.
46. Sirena, D., Lilienfeld, B., Eisenhut, M. & 8 other authors (2004). The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J Virol 78, 4454-4462.
47. Sprangers, M. C., Lakhai, W., Koudstaal, W., Verhoeven, M., Koel, B. F., Vogels, R., Goudsmit, J., Havenga, M. J. & Kostense, S. (2003). Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors. J Clin Microbiol 41, 5046-5052.
48. Stockwin, L. H., Matzow, T., Georgopoulos, N. T., Stanbridge, L. J., Jones, S. V., Martin, I. G., Blair-Zajdel, M. E. & Blair, G. E. (2002). Engineered expression of the coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer. J Immunol Methods 259, 205-215.
49. Stone, D., Ni, S., Li, Z. Y., Gaggar, A., DiPaolo, N., Feng, Q., Sandig, V. & Lieber, A. (2005). Development and assessment of human adenovirus type 11 as a gene transfer vector. J Virol 79, 5090-5104.
50. Tallone, T., Malin, S., Samuelsson, A., Wilbertz, J., Miyahara, M., Okamoto, K., Poellinger, L., Philipson, L. & Pettersson, S. (2001). A mouse model for adenovirus gene delivery. Proc Natl Acad Sci U S A 98, 7910-7915.
51. Thirion, C., Larochelle, N., Volpers, C., Dunant P., Stucka, R., Holland, P., Nalbantoglu, J., Kochanek, S. & Lochmuller, H. (2002). Strategies for muscle-specific targeting of adenoviral gene transfer vectors. Neuromuscul Disord 12, 30-39.
52. Thorley, B. R., Milland, J., Christiansen, D. & 9 other authors (1997). Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection. Eur J Immunol 27, 726-734.
53. Vogels, R., Zuijdgeest, D., van Rijnsoever, R. & 20 other authors (2003). Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of pre-existing adenovirus immunity. J Virol 77, 8263-8271.
54. Von Seggern, D. J., Kehler, J., Endo, R. I. & Nemerow, G. R. (1998). Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein. J Gen Virol 79, 1461-1468.
55. Von Seggern, D. J., Huang, S., Fleck S. K., Stevenson, S. C. & Nemerow, G. R. (2000). Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J Virol 74, 354-362.
56. Wu, E., Trauger, S. A., Pache, L., Mullen, T. M., von Seggern, D. J., Siuzdak, G. & Nemerow, G. R. (2004). Membrane cofactor protein is a receptor for adenoviruses associated with epidemic kerato-conjunctivitis. J Virol 78, 3897-3905.
57. Xiang, Z., Gao, G., Reyes-Sandoval, A., Cohen, C. J., Li, Y., Bergelson, J. M., Wilson, J. M. & Ertl, H. C. (2002). Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J Virol 76, 2667-2675.
58. Yannoutsos, N., Ijzermans, J. N., Harkes, C., Bonthuis, F., Zhou, C. Y., White, D., Marquet R. L. & Grosveld, F. (1996). A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection. Genes Cells 1, 409-419.
59. Zakhartchouk, A., Zhou, Y. & Tikoo, S. K. (2003). A recombinant El-deleted porcine adenovirus-3 as an expression vector. Virology 313, 377-386.